Deciphera Pharmaceuticals
- Membership Level
- Gold
- Company Headquarters
- Waltham, MA
- Contact Name
- Nelson Pope
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals is focused on discovering, developing, and bringing important new medicines to patients for the treatment of cancer. Enabled by our proprietary kinase switch control inhibitor platform, our drug candidates are designed to stop cancers from growing and spreading by inhibiting mutant forms or over expression of a family of enzymes called kinases. We have built a diverse pipeline of orally administered drug candidates, including a late-stage candidate for fourth-line GIST for which we filed a New Drug Application with the U.S. FDA in December 2019.
